Chemours Co (NYSE:CC) SVP Susan M. Kelliher bought 6,500 shares of the business’s stock in a transaction on Friday, May 17th. The stock was bought at an average cost of $23.06 per share, with a total value of $149,890.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Chemours stock opened at $22.41 on Tuesday. Chemours Co has a 12 month low of $22.36 and a 12 month high of $53.25. The stock has a market cap of $3.79 billion, a P/E ratio of 3.95, a PEG ratio of 0.35 and a beta of 2.20. The company has a debt-to-equity ratio of 5.18, a current ratio of 1.81 and a quick ratio of 1.04.

Chemours (NYSE:CC) last announced its earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.93 by ($0.30). Chemours had a net margin of 12.60% and a return on equity of 87.75%. The firm had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter last year, the business earned $1.41 earnings per share. The business’s revenue was down 20.5% compared to the same quarter last year. As a group, equities analysts expect that Chemours Co will post 4.22 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Thursday, May 16th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 4.46%. The ex-dividend date of this dividend is Wednesday, May 15th. Chemours’s dividend payout ratio (DPR) is 17.64%.

A number of institutional investors have recently made changes to their positions in CC. Cullen Frost Bankers Inc. purchased a new position in Chemours during the 1st quarter valued at about $26,000. Zions Bancorporation N.A. purchased a new position in Chemours during the 1st quarter valued at about $30,000. Enterprise Financial Services Corp boosted its holdings in Chemours by 306.5% during the 1st quarter. Enterprise Financial Services Corp now owns 935 shares of the specialty chemicals company’s stock valued at $34,000 after acquiring an additional 705 shares during the period. Financial Architects Inc boosted its holdings in Chemours by 39.2% during the 4th quarter. Financial Architects Inc now owns 1,421 shares of the specialty chemicals company’s stock valued at $40,000 after acquiring an additional 400 shares during the period. Finally, Coastal Investment Advisors Inc. purchased a new position in Chemours during the 1st quarter valued at about $40,000. Institutional investors own 82.18% of the company’s stock.

A number of research firms have recently weighed in on CC. ValuEngine upgraded Chemours from a “sell” rating to a “hold” rating in a report on Wednesday, March 20th. SunTrust Banks upgraded Chemours from a “hold” rating to a “buy” rating and increased their price target for the stock from $40.00 to $52.00 in a report on Monday, April 15th. Zacks Investment Research upgraded Chemours from a “sell” rating to a “hold” rating in a report on Monday, March 18th. Susquehanna Bancshares reiterated a “neutral” rating and set a $37.00 price target on shares of Chemours in a report on Tuesday, February 19th. Finally, Citigroup reiterated a “buy” rating and set a $43.00 price target on shares of Chemours in a report on Wednesday, February 20th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $46.00.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/susan-m-kelliher-purchases-6500-shares-of-chemours-co-cc-stock/3017392.html.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.

See Also: The Structure of a Futures Contract

Insider Buying and Selling by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.